Everett Rand Sutherland's Insider Trades & SAST Disclosures

Everett Rand Sutherland's most recent trade in Upstream Bio Inc. was a trade of 500,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 6, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Upstream Bio Inc.
Everett Rand Sutherland Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2025 500,000 500,000 - - Stock Option (Right to Buy)
Krystal Biotech Inc
Everett Rand Sutherland Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2024 5,000 5,000 - - Stock Option (Right to Buy)
Allakos Inc
Everett Rand Sutherland Director 01 Aug 2023 154,786 154,786 - - Stock Option (Right to buy)
Krystal Biotech Inc
Everett Rand Sutherland Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2023 6,800 6,800 - - Stock Option (Right to Buy)
Krystal Biotech Inc
Everett Rand Sutherland Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2022 6,800 6,800 - - Stock Option (Right to Buy)
Krystal Biotech Inc
Everett Rand Sutherland Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 13,600 13,600 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades